Christoph Schatz

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Endometrial Cancer

Top Venues

Antioxidants (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Christoph Schatz, Ludwig Knabl, Hye Kyung Lee, Rita Seeboeck, Dorothee von Laer, Eliott Lafon, Wegene Borena, Harald Mangge, Florian Prüller, Adelina Qerimi, Doris Wilflingseder, Wilfried Posch, Johannes Haybaeck
Machine Learning to Identify Critical Biomarker Profiles in New SARS-CoV-2 Variants. Microorganisms 12 (4) (2024)
Christoph Schatz, Ludwig Knabl, Hye Kyung Lee, Rita Seeboeck, Dorothee von Laer, Eliott Lafon, Wegene Borena, Harald Mangge, Florian Prüller, Adelina Qerimi, Doris Wilflingseder, Wilfried Posch, Johannes Haybaeck
Machine Learning to Identify Critical Biomarker Profiles in New SARS-CoV-2 Variants. Microorganisms 12 (4) (2024)
Tatiana S Driva, Christoph Schatz, Johannes Haybaeck
Endometriosis-Associated Ovarian Carcinomas: How PI3K/AKT/mTOR Pathway Affects Their Pathogenesis. Biomolecules 13 (8) (2023)
Elisabeth Reiser, Maria Victoria Bazzano, Maria Emilia Solano, Johannes Haybaeck, Christoph Schatz, Julian Mangesius, Ute Ganswindt, Bettina Toth
Unlaid Eggs: Ovarian Damage after Low-Dose Radiation. Cells 11 (7) (2022)
Tatiana S Driva, Christoph Schatz, Monika Sobocan, Johannes Haybaeck
The Role of mTOR and eIF Signaling in Benign Endometrial Diseases. International journal of molecular sciences 23 (7) (2022)
Lisa Schieffer, Claudia Manzl, Christoph Schatz, Johannes Haybaeck, Adriano Crismani
Nrf2 in the Field of Dentistry with Special Attention to NLRP3. Antioxidants (Basel, Switzerland) 11 (1) (2022)
Sabine Gufler, Rita Seeboeck, Christoph Schatz, Johannes Haybaeck
The Translational Bridge between Inflammation and Hepatocarcinogenesis. Cells 11 (3) (2022)
Christoph Schatz, Susanne Sprung, Volker Hans Schartinger, Helena Codina-Martínez, Matt Lechner, Mario A Hermsen, Johannes Haybaeck
Dysregulation of Translation Factors EIF2S1, EIF5A and EIF6 in Intestinal-Type Adenocarcinoma (ITAC). Cancers 13 (22) (2021)